[Mitochondrial benzodiazepine receptors (MBR) in association with neurological disorders]

Area of Science:

• Neuroscience
• Pharmacology
• Epilepsy Research

Background:

• Peripheral-type benzodiazepine receptor (PBR) agonists, such as Ro 5-4864, are known to affect neurological function.
• Epilepsy is a complex neurological disorder with various underlying mechanisms.
• Mitochondrial benzodiazepine receptors (MBR) are a subtype of PBR located in mitochondria.

Purpose of the Study:

• To investigate the role of peripheral-type benzodiazepine receptors (PBR) in an animal model of epilepsy (EL mice).
• To compare the PBR agonist sensitivity and MBR density between epileptic and control mice.
• To explore the potential of MBR as a therapeutic target for neurological disorders.

Main Methods:

• Administered Ro 5-4864, a PBR agonist, to EL mice (epilepsy model) and DDY mice (control).
• Conducted binding assays to quantify [3H] Ro 5-4864 binding sites in brain mitochondrial fractions.
• Utilized an elevated plus-maze to assess fear responses and fluorometric studies to examine mitochondrial membrane potential and intracellular calcium levels in NG108-15 cells.

Main Results:

• Ro 5-4864 elicited convulsions 2.6 times more potently in EL mice compared to DDY mice.
• EL mice exhibited a 50% higher density of mitochondrial benzodiazepine receptors (MBR) in brain tissues.
• PBR stimulation in EL mice led to fear responses and mitochondrial depolarization, with increased intracellular Ca2+.

Conclusions:

• Mitochondrial benzodiazepine receptor (MBR) hyperfunction may be implicated in the abnormal behaviors observed in EL mice, an epilepsy model.
• MBR represent a potential therapeutic target for neurological disorders.
• Development of drugs like "mitochondrial membrane stabilizers" could offer new treatment strategies for neurological conditions.